Sandoz
-
Biocon Biologics partners with Sandoz
Biocon Biologics will have exclusive rights to promote, sell and distribute Adalimumab BS for subcutaneous injection [FKB] in Japan Biocon…
Read More » -
Sandoz announces new global ‘Act4Biosimilars’ initiative
To improve patient access and increase adoption by at least 30% in 30+ countries by 2030 Sandoz announced the launch…
Read More »